Besides emricasan, an in vivo study by Morrison et al. showed that treatment with Ac-YVAD-cmk, another casp1 inhibitor, blocked NASH development and insulin resistance in male LDLR−/−.Leiden mice (70). The gene discussed is CASP1; the disease is Insulin resistance.